RT Journal Article
SR Electronic
T1 Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
JF Neurology
JO Neurology
FD Lippincott Williams & Wilkins
SP 1085
OP 1087
DO 10.1212/WNL.47.4.1085
VO 47
IS 4
A1 Wolters, E.Ch.
A1 Jansen, E.N.H.
A1 Tuynman-Qua, H. G.
A1 Bergmans, P. L.M.
YR 1996
UL http://n.neurology.org/content/47/4/1085.abstract
AB We studied the effect of olanzapine (1 to 15 mg/d) in 15 nondemented parkinsonian patients with drug-induced psychosis. Psychotic symptoms decreased significantly during treatment, and there was no worsening of extrapyramidal symptoms. These results suggest that olanzapine is a well-tolerated and effective treatment for drug-induced psychosis in nondemented patients with Parkinson's disease. NEUROLOGY 1996;47: 1085-1087